Achieve Life Sciences
ACHV
25 hedge funds and large institutions have $1.46M invested in Achieve Life Sciences in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
4% less funds holding
Funds holding: 26 → 25 (-1)
21% less capital invested
Capital invested by funds: $1.85M → $1.46M (-$395K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$28.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$14.6K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$12.2K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.05K |
| 5 |
Bank of New York Mellon
New York
|
+$3.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$33K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$30.8K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$19.5K |
| 4 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
-$17K |
| 5 |
BlackRock
New York
|
-$10.5K |
ACHV Hedge Fund Activity: Q2 2017 in Review
25 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2017, worth a combined $1.46M — down 21% from $1.85M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ACHV and 2 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 4 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $28.4K. The largest seller was UBS Group, exiting entirely with an estimated $33K sold.
- 25 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2017, down from 26 in Q1 2017.
- Funds reported $1.46M of Achieve Life Sciences stock for Q2 2017, down 21% quarter-over-quarter.
- 2 funds opened new Achieve Life Sciences positions in Q2 2017 and 3 closed out, a net change of -1 holder.
- The largest Achieve Life Sciences buyer in Q2 2017 was Susquehanna International Group, an estimated $28.4K added.
- The largest Achieve Life Sciences seller in Q2 2017 was UBS Group, an estimated $33K sold.
Based on aggregated 13F filings for Q2 2017.